KA, A., D, A., B, B., & TM, A. (2024). Pancreatitis with use of new diabetic medications: A real-world data study using the post-marketing FDA adverse event reporting system (FAERS) database. Frontiers in pharmacology, 15, 1364110. https://doi.org/10.3389/fphar.2024.1364110
Chicago Style (17th ed.) CitationKA, Alenzi, Alsuhaibani D, Batarfi B, and Alshammari TM. "Pancreatitis with Use of New Diabetic Medications: A Real-world Data Study Using the Post-marketing FDA Adverse Event Reporting System (FAERS) Database." Frontiers in Pharmacology 15 (2024): 1364110. https://doi.org/10.3389/fphar.2024.1364110.
MLA (9th ed.) CitationKA, Alenzi, et al. "Pancreatitis with Use of New Diabetic Medications: A Real-world Data Study Using the Post-marketing FDA Adverse Event Reporting System (FAERS) Database." Frontiers in Pharmacology, vol. 15, 2024, p. 1364110, https://doi.org/10.3389/fphar.2024.1364110.